Gan to kagaku ryoho. Cancer & chemotherapy · 2007
[A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
Клинический случайАннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iida Shinya, Furukawa Kiyonori, Yokoyama Tadashi, Yanagihara Keiko, Iwasaki Reiko, Noguchi Tomoko, Tsuchiya Shinichi, Sugisaki Yuichi, Naito Zenya, Tajiri Takashi
Аннотация
We report a case of elderly metastatic breast cancer with a complete response to the treatment with XC (X: capecitabine and C: cyclophosphamide). A 78-year-old woman, who presented with left breast cancer, underwent pectoralis-preserving mastectomy when she was 76 years old. Pathological findings were as follows: invasive ductal carcinoma (scirrhous type), pT1c (2.0 cm), n (1/10), ly3, v1, ER (-), PgR (-), HER2: score 1. After one year and a half, a left supraclavicular lymph node metastasis, a left interpectoral lymph node metastasis, and mediastinal lymph nodes metastasis were noted. Capecitabine and cyclophosphamide were administered as first-line chemotherapy. After 8 cycles, all metastases responded, and this therapy is now being continued (19 cycles) on an outpatient basis. The complete response has continued for nine months. XC therapy can be the first-line chemotherapy for elderly metastatic breast cancer patients since it has been effective and no serious side effects have been encountered while maintaining quality of life.
Предметные рубрики MeSH
AgedAntimetabolites, AntineoplasticAntineoplastic Agents, AlkylatingAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCapecitabineCarcinoma, Ductal, BreastCyclophosphamideDeoxycytidineDrug Administration ScheduleFemaleFluorouracilHumansLymphatic MetastasisNeoplasm MetastasisTreatment Outcome